Drug factory · FDA FEI 2916223
Nippon Sanso Matheson, Inc.
91-163 Haua St, Kapolei, HI, United States
Problems found, fixed voluntarily at FDA's last inspection, Jul 8, 2026.
Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.
2 drug inspections on record since 2014: 1 with no problems, 1 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Nitrogen | Makes it | Nippon Sanso Matheson, Inc. | 55037-201 |
| Oxygen | Makes it | Nippon Sanso Matheson, Inc. | 55037-113 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Jul 8, 2026 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Sep 25, 2014 | No problems found | Drug Quality Assurance | — |
Registered with FDA for: manufacture.